Leishmaniasis is a disease which is caused by the protozoa Leishmania and is considered the second-highest cause of death worldwide by parasitic infection. Looking for the right chemotherapy against leishmaniases has been difficult because of the high toxicity of the most effective drugs. Computational Chemistry plays an important role in the research of new possible medicines. In this work, docking analysis was carried out to study the effects of nine 2-substituted-4,5-difuryl Imidazole on Leishmania arginase, Leishmania trypanothione synthetase amidase and Leishmania trypanothione reductase and results were compared with three known drugs, and with targets potential inhibitors. ∆G, Ki and binding interactions in the targets active sites were reported. Results show that 4, 5-di (furan-2-yl)-2-(5-(4-nitrophenyl) furan-2-yl)-1H imidazole and 4-(5-(4,5-di(furan-2-yl)-1H-imidazol-2-yl) furan-2-yl) benzoic acid are promising leads, so the study of these compounds is recommended.
INTRODUCTION
Leishmanisis is located within the thirteen tropical diseases more neglected (WHO, 2016) , caused by over twenty different species of Leishmania parasite (e.g., L. donovoni, L. infantum, L. major, L. mexicana, etc.), we can find it in three clinical form: cutaneous (L. major, L. tropica and L. mexicana) , mucocutaneous (L. braziliensis) and visceral (L. donovani and L. infantum) (Loría and Andrade, 2014; Reithinger et al., 2007) . The diseases is transmitted by infected female Phlebotomine sandfly, a dipteran, which transmits the parasite to human during blood sucking (Myler and Fasel, 2008) . This malady is endemic from of Central and South American countries (Tempone et al., 2005) .
Due to its characteristics of opportunistic pathogen has generated great interest in the scientific community the need to control it. The proven treatment for Leishmanisis include the antimonials sodium stibogluconate (pentostam) and meglumine antimoniate (glucantime), but the adverse side effects associated with these compounds and drug resistance is emerging. However, alternative antileishmanial chemotherapies include the compounds amphotericin B and pentamidine, which are generally more toxic than the pentavalent antimonials (Arboleda et al., 2013; Sundar and Rai, 2002) .
So far, others drugs are used as replacement of these drugs, in some cases of uncertainly effective therapy such as allopurinol, the AmBisome ® (formulation of amphotericin B in liposomes) and ketoconazole (Jebran et al., 2014) . Nowadays, have grown the indentification of specific biological targets by the use of computational tools for the desing of new drugs with the aim to decreased illness. Within commnon tools used with this objective we can found the molecular docking and molecular dynamic, commonly used for elucidation of leishmaniasis targets and find out the interaction and dynamics of drugs and target at molecular level (Peitsch and Schwede, 2000) .
Imidazoles are an important group heterocycles that contain nitrogen and are currently under intensive studie due to their broad range of applications (Gharib et al., 2014) such as angiotensin inhibitors (Trujillo et al., 2009 ), anti-inflammatory (Palkowitz et al., 1994 , glucagon antagonist (Chang et al., 2001 ), antiviral (Sharma et al., 2009 , fungicidal, (Laufer and Koch, 2008; Kumar et al., 2003) , and high cytotoxicity, which has indicated them as new candidates in cancer therapy . Compounds containing imidazole moiety have many pharmacological properties and play important roles in biochemical processes (Lambardino and Wiseman, 1974) . The potency of the imidazoles can be attributed to its hydrogen bond donor-acceptor capability as well as its high affinity for metals (e.g., Zn, Fe, Mg), which are found in many protein active sites . Substituted imidazoles have been reported to possess anti-mycobacterial, antimicrobial, anthelmintic, antiinflammatory, anticonvulsant and insecticidal properties (Kumar et al., 2008; Manal et al., 2014; Safari et al., 2013) . Many studies showed that azole heterocycles such as imidazole and triazole are useful pharmacophores for anti-mycobacterial activity (Zampieri, 2009; Chauhan et al., 2010) .
In the present study, the structural models of 2-substituted-4,5-difuryl Imidazoles in the Trypanothione Synthetase (TSy), Trypanothione Reductase (TRe) and Arginase I (ArgI) binding sites have been created, which may facilitate further development of more potent antileishmanial agents. The overall scores were used to choose the final models. Protein-ligand dockings were performed between the molecular model of L. infantum TRe, L. major TSy and L. amazonensis ArgI and 2-substituted-4,5-difuryl Imidazoles. The analyses in-silico of probable inhibition and interaction models is not conclusive report on the antileishmanial activity of 2-substituted-4,5-difuryl Imidazoles, but will be useful to design molecules that may have antileishmanial activity.
MATERIALS AND METHODS

Computational Resource
Molecular modelling was performed using the Highperformance computing capabilities of the Cluster of Chemistry Department of University of Oriente running the Linux operating system Debian 7.0 distribution.
Ligands and Proteins Preparation for Docking
Autodock is a very popular open source docking program. The pdb file was prepared using the software UCSF Chimera molecular graphic system, version 1.10.227. The following target proteins with their Protein Data Bank (PDB) ID were selected, Trypanothione Reductase from Leishmania Infantum -PDB ID: 2JK6 (TRe), Trypanothione Synthetase from Leishmania major -PDB ID: 2VOB (TSy) and Arginase I from Leishmania amazonensis -PDB ID: 1T5F (ArgI). The different protein structures contain identical domains, for these proteins we used chain A for each protein. Finally, the resulting prepared 3D structure of the proteins was saved as PDB file. Using AutodockTools 1.5.6 (ADT) (Sanner, 1999) , Kollman united atom charges, solvation parameters and polar hydrogens were added to the protein for the preparation of the enzyme in the docking simulations. Since the ligands are not peptides, Gasteiger charges were assigned and non-polar hydrogens were merged.
ChemBioDraw (Evans, 2014) was used to draw the structures of 2-substituted-4,5-difuryl Imidazoles ( Figure 1 ) and designed taking into account reference (Speck et al., 2011) . ChemBio3D Ultra 12.0 (Evans, 2014) was used to optimize the geometry, running a MMFF94 energy minimization of the 3D structures. The Gasteiger (Gasteiger and Marsili, 1980 ) charge calculation method was used and partial charges were added to the ligand atoms before docking. 
Identification of binding site residues
The binding site residues for ArgI, TSy, and TRe from Leishmania amazoenesis were identified from the analysis of the Arginase I-AOH complex -PDB ID: 1T5F (Shin et al., 2004) , Trypanothione Synthetase -PDB ID: 2VOB (Fyfe et al., 2008) from Leishmania major and Structure of Trypanothione Reductase from Leishmania infantum -PDB ID: 2JK6 (Baiocco, 2009).
Grid box preparation and docking
Docking experiment were performed between 2-substituted-4,5-difuryl Imidazoles and different targets of Leishmania. AutoDock requires pre-calculated grid maps, one for each atom type, present in the ligand being docked. This grid stores the potential energy arising from the interaction with the macromolecule and must surround the region of interest (active site) in the macromolecule. Grid box parameters (Table 1) were set by using ADT. The molecular docking program AutoDock (version 4.2) (Sanner, 1999) was employed to perform the docking experiment. The Lamarckian Genetic Algorithm was used to explore the best conformational space for the ligand with a 50 docking runs for each ligand. The maximum numbers of generation and evaluation were set at 27000 and 2500000, respectively. Other parameters were set as default. After complete execution of Autodock fifty conformations of the ligands in complex with the receptor were obtained, which were ranked based on binding energy and inhibition constant (Ki).
Docking calculations can be validated by redocking ligands that were cocrystallized in the receptor structures (Arba et al., 2017) . However in our target structures, no inhibitors were present, so we opted for validation by docking some known antimicrobial drugs as Ketoconazole, Pentamidine and Miltefosine taken from DrugBank (Wishart et al., 2006) . They were built and docked (Figure 2 ). 
RESULTS AND DISCUSSION
Molecular docking studies of nine 2-substituted-4,5-difuryl Imidazoles (Figure 1 ) were carried out with three protein Trypanothione Reductase (TRe), Trypanothione Synthetase (TSy) and Arginase-I (ArgI) from the Leishmania infantum, Leishmania major and Leishmania amazoenesis parasite respectively, using Autodock 4.2, to identify the binding mode of ligands and the intermolecular interaction between ligands and different target proteins.
The poses docked for each of the compounds were evaluated and the pose with the lowest binding free energy and the inhibition constant was thereby chosen (Table 2) . The lowest binding free energy (i.e. best docking score) and inhibition constant indicated the highest ligand/protein affinity.
The docking studies were done in comparison with control compounds. As control compounds were used Ketoconazole, Pentamidine and Miltefosine (Figure 2 ), these drugs are used currently against the Leishmania parasites ( Rodrigues et al., 2012; Alam et al., 2012) .
The predicted binding free energy observed for ligand 7 was for TRe −9,12 kcal/mol, TSy −10.5 kcal/mol and ArgI −7.47 kcal/mol; ligand 9 binding is stabilized by −9.33 kcal/mol to TRe, −10.1 kcal/mol to TSy and −6.91 to ArgI. The inhibition constant value for ligand 7 and 9 result in very similar values, 0,21 and 0,18 μM for TRe, 0,02 and 0,04 μM for TSy and 3,34 and 8,65 μM for ArgI, respectively.
When the chemical structure of 7 and 9 (Figure 3 ) was compared, it was observed that both ligands possess two furyl rings joined to the imidazole ring, and also a furylphenyl group. The existence of these aromatic rings at the same position increases the length of the chain, the number of bond torsions and the accessibility of heteroatoms and substitutions from the amino acids residues of the enzyme in the active site. Therefore, an important number of hydrophobic interaction and hydrogen bonds exist that stabilize the enzyme-ligand complex. 
L. infantum TRe
Compound 7 was found (Table 3) Figure 4B ), and hydrophobic interaction with Ala365, Cys52, Cys364, Leu334, Pro336, Ser14, Tyr198 and Thr51 ( Figure 4B ) residues of TRe. Also, it was observed that compound 9 (Table   3) 
L. major TSy
On the other hand, compound 7 was found to interact by hydrophobic interactions with Ala596; Arg613; Glu587; Glu614; Ile597 and Tyr595 residues of TSy ( Figure 5A Figure 6A ) and hydrophobic interactions with Arg21; Cys19; Glu277; Gly142; His126; Pro20; Ser136 and Thr135, some of those residues Arg21, Glu277 y His126 are involved in the active site according to reference (Kanyo et al., 1996) . Also, it was observed that compound 9 interacts with Ala141; Arg21; Cys19; Glu277; Gly245; Pro20; Ser137 and Val24 residues of ArgI ( Figure 6B ) by hydrophobic interaction; as well it was found that compound 9 establishes a hydrogen bond with Lys68 [N-H….O] residue.
Control inhibitors
The control inhibitors were docked under the same docking conditions against the enzymes TRe, TSy and ArgI. The docked poses for each control inhibitors were evaluated and the pose with the lowest binding free energy and the inhibition constant was thereby chosen. These results were compared with the better ligands 7 and 9 (Table 4) . According to these results, both compounds 7 and 9 showed similar behavior against the enzymes TRe, TSy and ArgI, but compared with the control compounds, both ligands showed higher stability than the Pentamidine and Miltefosine drugs, only surpassed by the control Ketoconazole for the enzymes L.infantum TRe and L. amazonenesis ArgI (Table 4) .
Ketoconazole showed an inhibition constant of 0,068 μM and a binding free energy of −9.77 kcal/mol; both values are similar to ligands 7 and 9 for TRe (Table 4) . These similar values are due to similar structural conformation inside the enzyme TRe (Figure 7) . For L. infantum TRe the Ketoconazole interacted with Leu334, Pro336, Cys364, Ala363, Ala365, Thr335, Lys60, Phe367, Met333, Tyr198, Thr51, Cys57, Arg287, Ser162, Gly161 and Asp327 residues (Figure 7 ), in this case share following interacting residues with ligands 7 and 9: Leu334, Pro336, Cys364, Cys57, Ala365 and Thr335; some of them involved in the active site of TRe (Baiocco et al., 2009) .
The predicted binding free energies observed for Ketoconazole with L. major TSy was 9.81 kcal/mol, in this case ligands 7 and 9, showed better values (Table 4 ) compared with this control drug. The residues Met251, Val263, Ser264, Phe626, Glu355, Ala627, Trp363, Ile612, Gln360, Cys356, Ala628, Arg613, Gly611, Gly599, Thr352 and Trp601 interacted with Ketoconazole ( Figure 8 ). As we can observe in this figure, there exists a good superimposition between the ligand 7 and 9 with Ketoconazole inside the protein target L. major TSy.
For target ArgI the predicted free energies for Ketoconazole was −7.98 kcal/mol, with residues Cys19, Gly245, Pro20, Glu277, Ala141, Asn139, Thr246, Gly142, His126, Asp128, Glu186, Asp183, Asp181, Val182, Arg21 interacting with Ketoconazole ( Figure 9 ). In this case ligands 7 and 9 share some interacting residues: Asp128, Asp183, Glu186, Asn130, Asp124, Glu277, His101, Asp232, Asp234 involved in the active site of ArgI (Figure 9 ) (Shin et al., 2004) . The superimposition inside the binding site of ArgI of ligand 7 and 9 with Ketoconazole is not good unlike in the case of proteins TSy and TRe. Fig. 5 : Protein-ligand interaction 2D map of ligand 7 (A) and 9 (B) with TSy protein using Ligplot (Wallace et al., 1996) .
Fig. 6:
Protein-ligand interaction 2D map of ligand 7 (A) and 9 (B) with ArgI protein using Ligplot (Wallace et al., 1996) .
Comparison with other molecular docking study in the same proteins
In Table 5 , we show published reports of molecular docking of possible inhibitory substances and the same target enzymes under study, under calculation conditions very similar to ours and compared with the data obtained in the present work of one of our potentially more active imidazoles. As shown in Table 5 in all cases, the values calculated for imidazole 2-[5-(4-nitrophenyl) furyl]-4,5-difurylimidazole (compound 7) indicate greater stability in the coupling with the enzymes than the inhibitors reported by other authors. This assessment is analogous for the imidazole 2-[5-(4-carboxyphenyl)furyl]-4,5-difurylimidazole (compound 9), even in some cases for other imidazoles studied which were not selected in this work as the most potentially active (see Table 2 ). The structures of the control inhibitors are markedly different from imidazoles (see Figures 2A, 2B) , which explains the little coincidence in the interactions in the complexes formed by them with the corresponding enzymes and those found for 2-[5-(4-nitrophenyl)furyl]-4,5-difurylimidazole (compound 7). Fig. 9 : Superimposition of control Ketoconazole (tan) with ligand 7 (sky blue) and 9 (orchid) against the enzyme L. amazonensis ArgI. 
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